Obesity and gastrointestinal cancer
- PMID: 20306531
- DOI: 10.1002/bjs.7079
Obesity and gastrointestinal cancer
Abstract
Background: There is emerging evidence of a strong association between obesity and gastrointestinal cancer. This review summarizes the evidence from an epidemiological and pathophysiological perspective.
Methods: Relevant medical literature was identified from searches of PubMed and references cited in appropriate articles were identified. Selection of articles was based on peer review, journal and relevance.
Results: Numerous epidemiological studies consistently identified an increased risk of developing oesophageal adenocarcinoma and colorectal carcinoma in the obese. The association between obesity and other gastrointestinal malignancies was less robust. Sex seems important with respect to cancer risk. Adipose tissue, particularly viscerally located fat, is metabolically active and exerts systemic endocrine effects. Putative pathophysiological mechanisms linking obesity and carcinogenesis include the insulin-like growth factor axis, adipocytokines and sex steroids.
Conclusion: A better understanding of the mechanisms that link obesity and cancer may uncover targets for intervention. Tackling obesity may result in a reduction in the incidence in addition to mortality of certain cancers in future.
Copyright 2010 British Journal of Surgery Society Ltd.
Similar articles
-
Energy balance, physical activity, and cancer risk.Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3. Methods Mol Biol. 2009. PMID: 19107429 Review.
-
Leptin and gastro-intestinal malignancies.Obes Rev. 2010 Dec;11(12):863-74. doi: 10.1111/j.1467-789X.2010.00718.x. Obes Rev. 2010. PMID: 20149119 Review.
-
Review article: steatosis, the metabolic syndrome and cancer.Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:40-3. doi: 10.1111/j.1365-2036.2005.02594.x. Aliment Pharmacol Ther. 2005. PMID: 16225471 Review.
-
Visceral adiposity, insulin resistance and cancer risk.Diabetol Metab Syndr. 2011 Jun 22;3:12. doi: 10.1186/1758-5996-3-12. Diabetol Metab Syndr. 2011. PMID: 21696633 Free PMC article.
-
Obesity, type 2 diabetes and risk of digestive cancer.Gastroenterol Clin Biol. 2010 Oct;34(10):529-33. doi: 10.1016/j.gcb.2010.07.021. Gastroenterol Clin Biol. 2010. PMID: 20864282 Review.
Cited by
-
Efficacy and safety of Gelidium elegans intake on bowel symptoms in obese adults: A 12-week randomized double-blind placebo-controlled trial.Medicine (Baltimore). 2019 Apr;98(17):e14981. doi: 10.1097/MD.0000000000014981. Medicine (Baltimore). 2019. PMID: 31027051 Free PMC article. Clinical Trial.
-
Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.J Gastrointest Oncol. 2014 Feb;5(1):67-76. doi: 10.3978/j.issn.2078-6891.2013.054. J Gastrointest Oncol. 2014. PMID: 24490044 Free PMC article.
-
Anti-Obesity Effects of Grateloupia elliptica, a Red Seaweed, in Mice with High-Fat Diet-Induced Obesity via Suppression of Adipogenic Factors in White Adipose Tissue and Increased Thermogenic Factors in Brown Adipose Tissue.Nutrients. 2020 Jan 24;12(2):308. doi: 10.3390/nu12020308. Nutrients. 2020. PMID: 31991562 Free PMC article.
-
Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.Am J Gastroenterol. 2015 Feb;110(2):310-9. doi: 10.1038/ajg.2014.422. Epub 2015 Jan 13. Am J Gastroenterol. 2015. PMID: 25583325
-
A 12-year trend analysis of the incidence of gastrointestinal cancers in East Azerbaijan: last updated results of an ongoing population-based cancer registry.BMC Cancer. 2019 Aug 7;19(1):782. doi: 10.1186/s12885-019-6008-3. BMC Cancer. 2019. PMID: 31391032 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical